Patent · US Active

Compounds and compositions for treating hematological disorders

US11419875B2 · kind B2 · utility

4Cited by

9References

51Claims

0Family size

Assignee

Aurigene Discovery Technologies Limited · IN

Inventors

Venkateshwar Rao Gummadi · Bengaluru, IN
Susanta Samajdar · Savanuru, IN
Kavitha Nellore · Bengaluru, IN
Girish Chandrappa Daginakatte · Kanchinakote, IN
Wesley R. Balasubramanian · Hosur, IN

Key dates

Filing date	Mar 30, 2018
Grant date	Aug 23, 2022
Priority date	—
Expiry date	Oct 17, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides methods of treating hematological disorders, such as acute myeloid leukemia, using substituted heterocyclic compounds and pharmaceutically acceptable salts thereof. The compounds inhibit IRAK4 and FLT-3 kinases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.